Conducting clinical trials for Lyme disease drug? Head to N.J., Wisconsin

If you’re looking to do clinical trials for Lyme disease-related treatments, new research funded by the Centers for Disease Control and Prevention shows that New Jersey and Wisconsin are hot spots for the disease.Durland Fish, a professor of Epidemiology at Yale School of Public Health, said the researchers had found of a search of 300 [...]

[Read more of this report]


Minnesota device maker Synovis to be acquired by Baxter International

Minnesota’s Synovis Life Technologies Inc. is being acquired by Baxter International Inc. in a $325 million deal, the companies announced today.Synovis’ board unanimously approved the buy at $28 per share. Pending shareholder approval, the deal is expected to close in the first quarter of 2012.The maker of biological and mechanical products for surgeries generated $68.6 [...]

[Read more of this report]


Baxter Ventures will use $200 million for early-stage companies (Best of MedCitizens)

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCitynews.com.Now here’s the best of what YOU had to say:Baxter Ventures will invest $200 million in early-stage companies. Baxter International put aside $200 million in equity to invest in early-stage companies that [...]

[Read more of this report]


Baxter Ventures will invest $200 million in early-stage companies

Baxter International Inc. (NYSE:BAX) put aside $200 million in equity to invest in early-stage companies that “complement” its portfolio.The newly established ” Baxter Ventures will invest globally and focus on innovative technologies with sustainable long-term growth” under the watch of the Deerfield, Ill.-based company’s chief scientific officer Norbert Riedel, according to [...]

[Read more of this report]


Baxter selling generic injectables business to U.K. firm

Baxter International Inc. (NYSE:BAX) is planning to offload its U.S.-based generic injectables business to British drug firm Hikma Pharmaceuticals PLC (LSE:HIK).The deal is worth about $112 million to the Deerfield, Illinois-based company, according to a statement.The agreement is comprised of Hikma acquisition of Baxter’s injectable products in vials and ampules, [...]

[Read more of this report]


Some hospitals make huge profits (Morning Read)

The average American hospital barely breaks even, according to Forbes’ first survey of America’s most profitable hospitals. But the most profitable hospital in the country — 235-bed Flowers Medical Center in Dothan, Alabama — recorded a 53 percent operating margin and belongs to the for-profit Community Health Systems (NYSE: CYH) chain in Brentwood, Tennessee.

[Read more of this report]


Nutter to leave Haemonetics in November

Former CEO and company chairman Brad Nutter announces retirement from the Braintree, Mass.-based blood management company after seven years.Brad Nutter, the turnaround artist who helped pump new life into Haemonetics Corp. (NYSE:HAE) as CEO and later chairman of the board, said he will retire from the company’s board of directors effective [...]

[Read more of this report]


Cardinal, Baxter among companies FDA asks to probe blood stream infections

The U.S. Food & Drug Administration said it is requiring nine medical device companies to conduct postmarket analysis on a connection between needless connectors and higher rates of blood stream infections.In a notice posted on the Centers for Devices and Radiological Health web site, officials said that the agency is “aware of [...]

[Read more of this report]


Baxter profits fall 9% on settlement with Greece

Baxter International Inc.’s (NYSE:BAX) profits fell 9 percent due to higher costs and big write-down from a settlement with the government of Greece.The Deerfield, Ill.-based medical device and vaccine maker posted net income of $535 million for the three months ended June 30, down 9 percent from $587 million during the same period last year. [...]

[Read more of this report]


FDA issues final order for Baxter infusion pump recall

The U.S. Food & Drug Administration’s recall covers as many as 200,000 of Baxter International Inc.’s Colleague infusion pumps.The Food & Drug Administration issued its final order for the U.S. recall of Baxter International Inc.’s (NYSE:BAX) Colleague infusion pumps.The federal watchdog is requiring the Deerfield, Ill.-based company to provide transition guide [...]

[Read more of this report]


Older Posts »

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics